Article | July 21, 2016

The Right Biomanufacturing Partner Can Improve Flexibility And Mitigate Risks From Forecasting

Source: Patheon, part of Thermo Fisher Scientific
biomanufacturing forecasting

ORC International’s report “Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing” explores the causes, consequences, and potential solutions to forecasting challenges specifically related to biopharmaceu­tical drug substance manufacturing. Bioprocess Technology Consultants’ (BPTC) analysis provides further insight and perspective on the key themes that emerge from the report and offers additional solutions to companies to better prepare for the inevitable forecast inaccuracies for biopharmaceuticals.

While forecasts can never be 100% accurate, the goal for biopharmaceutical forecasters should be to minimize the degree of inaccuracies as much as possible. To reduce the impact of inaccurate forecasting over the life cycle of a product, companies need to focus on those variables that they have the most control over.

Patheon, part of Thermo Fisher Scientific